BIOQUAL, Inc.
BIOQ
$72.50
-$2.50-3.33%
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -4.84% | -1.47% | -12.40% | -17.65% | 9.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.84% | -1.47% | -12.40% | -17.65% | 9.71% |
| Cost of Revenue | 2.28% | 3.71% | 1.82% | -3.77% | 9.65% |
| Gross Profit | -30.35% | -18.36% | -33.39% | -88.47% | 9.90% |
| SG&A Expenses | 8.72% | 6.11% | 6.28% | 21.32% | 6.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.07% | 4.01% | 3.34% | -1.26% | 9.28% |
| Operating Income | -69.20% | -40.28% | -160.21% | -233.36% | 13.35% |
| Income Before Tax | -63.44% | -36.53% | -157.55% | -233.04% | 13.53% |
| Income Tax Expenses | -65.63% | -40.27% | -332.27% | -233.02% | 13.47% |
| Earnings from Continuing Operations | -62.54% | -34.99% | -137.20% | -233.05% | 13.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.54% | -34.99% | -137.20% | -233.05% | 13.55% |
| EBIT | -69.20% | -40.28% | -160.21% | -233.36% | 13.35% |
| EBITDA | -49.69% | -25.25% | -119.51% | -160.47% | 17.53% |
| EPS Basic | -62.54% | -34.99% | -137.20% | -233.05% | 13.55% |
| Normalized Basic EPS | -63.44% | -36.54% | -157.55% | -233.05% | 13.53% |
| EPS Diluted | -62.67% | -34.99% | -137.44% | -233.05% | 13.91% |
| Normalized Diluted EPS | -63.44% | -36.54% | -157.55% | -233.05% | 13.52% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -50.00% | -- | -- |
| Payout Ratio | 0.33% | -- | -- | -- | -0.30% |
